The Greenberg Bladder Cancer Institute | Johns Hopkins Medicine, based in Baltimore, Maryland

About Bladder Cancer

Smoking and industrial chemicals raise your risk. Get more facts and connect to in-depth info.
Our Approach to Care

A multidisciplinary team collaborates to provide customized precision care every step of the way.
Bladder Cancer Treatment

From proven protocols to promising clinical trials, you have options. We'll educate and guide you.
JHGBCI Newsletter

Learn more about the JHGBCI in the latest edition of our e-newsletter.
June 2020 Director's Update

Dr. McConkey provides important updates as the Institute reactivates clinical & research programming post COVID19.
Slideshow Correction

Slide 8 from the June 2020 Director's Update contained an error. Pembrolizumab (Keytruda) was incorrectly labeled. Click here to view corrected slides.

John talks about his experience working with the Greenberg Bladder Cancer Institute

Patient Story

Meet a Bladder Cancer Survivor: John’s Story

After receiving a bladder cancer diagnosis, John and his girlfriend, Jean, were determined to find the best care, which led them to Trinity Bivalacqua, M.D., Ph.D., of the Johns Hopkins Brady Urological Institute and Greenberg Bladder Cancer Institute. John shares his Johns Hopkins experience and the choices he made along his journey.

View John's Story

As a virtual institute, we partner with other leading experts around the world to share knowledge and collaborate on a global research agenda. Exciting advancements in bladder cancer research are happening right now. At the Greenberg Institute, we’re working to ensure these developments make a difference in patient lives — the sooner the better.

About the Institute

Meet Our Team

Meet Dr. McConkey

David J. McConkey, Ph.D. is the inaugural director of the Johns Hopkins Greenberg Bladder Cancer Institute and Professor in the Department of Urology at Johns Hopkins Medicine. His mission is to make the Institute a hub of an institutional and international community of researchers who share a commitment to advancing the scientific understanding of bladder cancer and improving its treatment.